Drugs Made In America Acquisition II Corp. (DMII) Total Non-Current Liabilities (2025 - 2026)

Drugs Made In America Acquisition (DMII) has reported Total Non-Current Liabilities for 2 consecutive years, with $17.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $17.5 million in Q2 2026; TTM through Jun 2026 was $17.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $17.5 million, changed N/A from the prior year.
• Total Non-Current Liabilities was $17.5 million for Q2 2026 at Drugs Made In America Acquisition, roughly flat from $17.5 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $17.5 million in Q4 2025 and troughed at $17.5 million in Q4 2025.